ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
Nevro Corp

Nevro Corp (NVRO)

4.57
0.07
(1.56%)
마감 18 1월 6:00AM
4.57
0.00
(0.00%)
시간외 거래: 7:11AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
4.57
매수가
-
매도가
-
거래량
388,855
4.44 일간 변동폭 4.66
3.165 52주 범위 19.47
market_cap
전일 종가
4.50
개장가
4.60
최근 거래 시간
37122
@
4.57
마지막 거래 시간
재정 규모
US$ 1,763,225
VWAP
4.5344
평균 볼륨(3m)
598,892
발행 주식
37,471,622
배당수익률
-
주가수익률
-1.86
주당순이익(EPS)
-2.46
매출
425.17M
순이익
-92.21M

Nevro Corp 정보

Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of lea... Nevro Corp is a medical device company. Its key product is the Senza spinal cord stimulation system, a neuromodulation platform for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. Nevro generates the majority of its revenue in the United States. It also receives nearly half of its revenue from Australia, the United Kingdom, and Germany. 더 보기

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Nevro Corp is listed in the Surgical,med Instr,apparatus sector of the 뉴욕 증권거래소 with ticker NVRO. The last closing price for Nevro was US$4.50. Over the last year, Nevro shares have traded in a share price range of US$ 3.165 to US$ 19.47.

Nevro currently has 37,471,622 shares in issue. The market capitalisation of Nevro is US$168.62 million. Nevro has a price to earnings ratio (PE ratio) of -1.86.

NVRO 최신 뉴스

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results

Nevro Announces Preliminary Fourth-Quarter and Full-Year 2024 Revenue Results PR Newswire REDWOOD CITY, Calif., Jan. 13, 2025 Cash, Cash Equivalents and Short-Term Investments...

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 PR Newswire REDWOOD CITY, Calif., Dec. 17, 2024 REDWOOD CITY, Calif., Dec. 17, 2024 /PRNewswire/ -- Nevro Corp. (NYSE:...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.1935.20710059173.384.573.1659929794.00885433CS
40.9827.29805013933.594.573.1655858063.8700963CS
12-0.33-6.734693877554.96.853.1655988924.42048202CS
26-5.5-54.617676266110.0710.373.1655945565.34151665CS
52-13.39-74.554565701617.9619.473.1655564058.52970288CS
156-86.42-94.977470051790.9990.993.16556720028.58818229CS
260-119.63-96.3204508857124.2188.143.16551715763.58062478CS

NVRO - Frequently Asked Questions (FAQ)

What is the current Nevro share price?
The current share price of Nevro is US$ 4.57
How many Nevro shares are in issue?
Nevro has 37,471,622 shares in issue
What is the market cap of Nevro?
The market capitalisation of Nevro is USD 168.62M
What is the 1 year trading range for Nevro share price?
Nevro has traded in the range of US$ 3.165 to US$ 19.47 during the past year
What is the PE ratio of Nevro?
The price to earnings ratio of Nevro is -1.86
What is the cash to sales ratio of Nevro?
The cash to sales ratio of Nevro is 0.4
What is the reporting currency for Nevro?
Nevro reports financial results in USD
What is the latest annual turnover for Nevro?
The latest annual turnover of Nevro is USD 425.17M
What is the latest annual profit for Nevro?
The latest annual profit of Nevro is USD -92.21M
What is the registered address of Nevro?
The registered address for Nevro is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Nevro website address?
The website address for Nevro is www.nevro.com
Which industry sector does Nevro operate in?
Nevro operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ARLAmerican Realty Investors Inc
US$ 15.93
(15.02%)
10.76k
RBOTVicarious Surgical Inc
US$ 16.382
(14.88%)
52.57k
AUNAAuna SA
US$ 8.45
(14.81%)
233.16k
MYTEMYT Netherlands Parent BV
US$ 9.45
(12.23%)
354.61k
BKSYBlackSky Technology Inc
US$ 11.71
(12.06%)
1.7M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M
DMDesktop Metal Inc
US$ 2.19
(-9.88%)
547.32k
JKSJinkosolar Holdings Co Ltd
US$ 21.23
(-9.81%)
1.55M
BODIBeachbody Company Inc
US$ 6.60
(-9.59%)
19.82k
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
FFord Motor Company
US$ 10.18
(1.70%)
60.8M
BBDBanco Bradesco SA
US$ 1.96
(-1.01%)
59.92M
VALEVale SA
US$ 8.94
(1.94%)
59.4M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M

NVRO Discussion

게시물 보기
TrendTrade2016 TrendTrade2016 2 일 전
NVRO STRONG IN A BAD MARKET
👍️0
TrendTrade2016 TrendTrade2016 3 일 전
NVRO STRONG INTO 2025
👍️0
TrendTrade2016 TrendTrade2016 5 일 전
NVRO MONSTER
👍️0
TrendTrade2016 TrendTrade2016 5 일 전
NVRO BIO BEAST TAKING OFF
👍️0
whytestocks whytestocks 5 년 전
News: $NVRO Here's Why Nevro Stock Bounded Higher on Thursday

Shares of Nevro   (NYSE: NVRO) , a medical device company with a focus on pain management, are soaring in response to a positive third-quarter earnings report. The company reported earnings and revenue that blew past analyst expectations, and raised guidance for the rest of 2019. As a...

Find out more NVRO - Here's Why Nevro Stock Bounded Higher on Thursday
👍️0
joseytheoutlawwales joseytheoutlawwales 5 년 전
New system with both lower frequency ranges and combination therapies, in addition to HF10 (10k Hz) ranges, and brand new patient peripherals (ie, remote, charger, etc) should be out in November I’m told.

Should be interesting.
👍️0
whytestocks whytestocks 6 년 전
News: $NVRO Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress

SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10Ȓ...

In case you are interested https://marketwirenews.com/news-releases/nevro-to-highlight-substantial-body-of-clinical-evidence-supporting-expanded-applications-and-unique-capabilities-of-hf10-therapy-at-the-14th-international-neuromodulation-society-world-congress-8248992.html
👍️0
stocktrademan stocktrademan 6 년 전
NVRO buy 61.44



normal chart







log chart






👍️0
KOmani KOmani 7 년 전
Down 14% on no news at all ....

Perhaps a little overdone?
👍️0
jimmybob jimmybob 8 년 전
$NVRO now up 49.3% YTD,closing at another all-time high today,and hitting all-time highs intra-day.. story not over… http://www.optionmillionaires.com/bull-case-nevro-nvro-update/
👍️0
jimmybob jimmybob 8 년 전
The Bull Case on Nevro ( $NVRO ) - Update : http://www.optionmillionaires.com/bull-case-nevro-nvro-update/ $MEDT $STJ $BSX $NURO $ETRM
👍️0
BudFoxWallStreet BudFoxWallStreet 8 년 전
Nevro's Revenue Surges, Lower Than Expected Loss |

https://www.medtechy.com/the-ticker/articles/2016/nevros-revenue-surges-lower-than-expected-loss

👍️0
jimmybob jimmybob 8 년 전
Snapshot on why I have/continue to love $NVRO (CC still going w/ speechless analysts) - http://www.optionmillionaires.com/bull-case-nevro-nvro/

👍️0
jimmybob jimmybob 9 년 전
One of the best growth stories out there, $NVRO revenue up 114% in ’15 looking for 137%+ in ’16

👍️0
jimmybob jimmybob 9 년 전
$NVRO - strong support around $65 , like for new all-time highs before Q1 earnings in May

👍️0
jimmybob jimmybob 9 년 전
Love the breakout on $NVRO friday.. $70+ next

👍️0
BudFoxWallStreet BudFoxWallStreet 9 년 전
Here is Nevro's JP Morgan presentation. They are also presenting at Leerink tomorrow but it is probably the same presentation.

https://www.medtechy.com/boards/companies/nevro/3825

👍️0
jimmybob jimmybob 9 년 전
Key theme from $NVRO @ #JPM16 : ’Expanding Market opportunities’ outside of $1.5 addressable market where its already taking sizable share
👍️0
RealGenius RealGenius 9 년 전
No way 1 billion MC justified here, when not even profitable.
👍️0
quaerere quaerere 9 년 전
Today Nevro submitted and posted a link to their preliminary response to the patent trial and appeals board with reference to the Boston Scientific Corporation challenge to the key Nevro patent.
See http://www.nevro.com/press-release/?r=US&prid=5aa76c3f-164d-4b00-8def-f9ad36ba33b2. I personally, though not a lawyer, was impressed by the strength of the rebuttal.
On another note, I have heard that the first few patients in my state that have received the preliminary trial for effectiveness of the Senza have faired well, and are going to move on to permanent implants. A number of advisory services have not been favorably viewing Nevro, but IMO that is because they are looking at past performance and not considering the game change that FDA approval represents. Others that look at the whole picture, such as Zacks, are very high on NVRO (Rank 1).
Long on NVRO, and added on the recent dip. The sparseness of contributions to this board is an indication that the stock is flying under the radar. I was clued in when the Senza was recommended for my spouse.
👍️0
stocktrademan stocktrademan 10 년 전
$NVRO recent news/filings

bullish

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com

[img]http://charts.stockscores.com/chart.asp?

TickerSymbol=NVRO&TimeRange=400&Interval=d&Volume=1&ChartType=CandleStick&ChartWidth=830&ChartHeight=500&LogSc

ale=None&Band=BB&avgType1=EMA&movAvg1=50&indicator1=MACD&candles=redgreen[/img]

big daily chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]dhclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

big weekly chart ## source: stockcharts.com

[img]stockcharts.com/c-sc/sc?chart=NVRO,uu[e,a]whclyiay[uu][pb5!b10!b50!b100!b200!d20,2!h.02,.20!f][vb5!b20]

[iut!lv8!lk9!LE12,26,9!ll14!la6,13,5!la8,17,9!la12,26,9!uc14!ub14!ub6!lo!lp7,3!lh9,3!LI14,3!lxa!ld8!lq!lg14!

lf14][j20444984,y]&r=3555b[/img]

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NVRO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NVRO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NVRO+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/news - http://finance.yahoo.com/q/h?s=NVRO

+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NVRO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NVRO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NVRO
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apple%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apple%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apple%2C

+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apple.com/pr
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apple.com/pr#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apple.com/pr

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NVRO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?

action=getcompany&CIK=0000320193&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NVRO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NVRO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NVRO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NVRO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NVRO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NVRO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NVRO+NVROh+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NVRO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NVRO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NVRO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NVRO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NVRO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NVRO/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NVRO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NVRO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NVRO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NVRO
Bussinessweek (businessweek.com):

http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NVRO
StockTwits (stocktwits.com): http://stocktwits.com/symbol/NVRO

$NVRO DD Notes ~ http://www.ddnotesmaker.com/NVRO
👍️0
uptowndw uptowndw 10 년 전
WTF???? huge jump but on only 2k shares how is this possible?????
👍️0
Penny Roger$ Penny Roger$ 10 년 전
My back hurts. Congrats on IPO $NRVO!

https://www.google.com/finance?q=NVRO

Nevro Corp. is a medical device company focused on developing solutions in the neuromodulation space. The Company provides pain relief to the customers suffering from low back pain and types of chronic pains. The Company’s High-frequency spinal cord stimulation (SCS) system, the HF10 SCS, is a spinal cord simulation therapy, which provides electric pulses at a rate of approximately 10,000 Hz for spinal cord stimulation in the treatment of chronic back and leg pain. The electrical pulses are conveyed by small electrodes placed in the epidural space and connected to a battery-powered generator implanted under the skin. The Nevro Senza SCS system is available in Europe and Australia. It is undergoing a pivotal clinical trial, which is intended to collect data to support an application for a Nevro Senza implantable spinal cord stimulation system. The Company’s SENZA-RCT study is intended to evaluate the safety and effectiveness of the Senza SCS system.
👍️0